High Quality EQ 200 / Test E 200 in UK

EQ 200 / Test E 200

Manufacturer – Dragon Pharma
Package – 10ml vial (400mg/ml)
Active substance – Boldenone Undecylenate (Equipoise), Testosterone Enanthate

EQ 200 / Test E 200 is produced by Dragon Pharma and contains a mixture of two steroids. These are Boldenone Undecylenate (Equipoise) and Testosterone Enanthate, a long-acting ester. This product has been designed to help the user gain muscle mass with the least chance of developing side effects.

Effects of Boldenone Undecylenate and Testosterone Enanthate

The active substances in the steroid mix have anti-catabolic and anabolic effects.

A well deigned cycle with the correct duration of use will provide the following results:

• Increase in fitness and stamina.
• Increased pumps and performance.
• Increased sexual activity
• Increased vascularity.

Side effects of the drug

The side effects are due to Testosterone Enanthate’s tendency to aromatize.

Due to this, possible side effects include:

• Water retention.
• Subcutaneous fat accumulation.
• Gynecomastia.

Aromatase inhibitors such as Anastrozole should be used during a cycle of EQ 200 / Test E 200 in order to reduce the side effects related to Testosterone Enanthate. To help restore the production of natural testosterone, anti-estrogens are also used at the end of a cycle.

Using Equipoise 200mg and Test E 200mg

Athletes that have prior experience can combine the drug with Stanozolol, Turinabol, and other AAS.

Experience, individual characteristics, and level of training is what decides the dosage and duration of the use of the drug.

Solo cycles should consist of no more than 1000mg a week (Beginners) and for experienced athletes a dosage of up to 2000mg a week.

No matter what happens, the length of the cycle should not be longer than 6 – 10 weeks. Exceeding the recommended dosage and length of use will only harm the user and bring about side effects so avoid abusing the drug. EQ 200 / Test E 200 is available for you to buy from our online store in the UK.